Molecular assessment of resistance markers for antimalarial drugs in Tanzania
Antimalarial drug resistance is one of the biggest threats to the treatment and control of malaria, with resistance now confirmed to all currently available antimalarials although critically resistance to the most pivotal artemisinins has not yet reached Africa but it currently confined to the Greater Mekong Subregion. New approaches, knowledge and skills-sharing are urgently needed to advance malaria control in Tanzania. One important way to track drug resistance and guide treatment policy is through genotyping polymorphisms in the parasite DNA that are associated with resistance to particular antimalarials. Therefore the current study aims to conduct a molecular surveillance to assess resistant molecular markers associated with Artemisinin-based combination therapies which are commonly used as first line antimalarial treatment in Tanzania.
Date: 2 May 2017, 12:30 (Tuesday, 2nd week, Trinity 2017)
Venue: NDM Building, Headington OX3 7FZ
Venue Details: Basement Seminar Room
Speaker: Dr Deborah Sumari (Ifakara Health Institute)
Organising department: Centre for Tropical Medicine and Global Health
Organiser: Dr Georgina Humphreys (WWARN, University of Oxford)
Organiser contact email address:
Part of: Tropical Medicine Seminars
Booking required?: Not required
Cost: free of charge
Audience: Public
Editors: Claire Escher Kessler, Tuula Itkonen